MedPath

sing antioxidants with oral contraceptives

Phase 2
Conditions
oral contraceptive pill taking.
Oral contraceptives
Registration Number
IRCT201109267641N1
Lead Sponsor
Shiraz university of medical sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
120
Inclusion Criteria

Iranian; age between 18-40; body mass index (BMI) 19-25; not using other supplement drugs and vitamin during the previous 3 months; not using cigarette and alcohol; not using special drugs; not having any known disease; using contraceptive pills for at least 1 and maximum 10 years; not having breast feeding. Excluding criteria: some special disease during study; changing the pregnancy prevention way during study; exit from study or immigration.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ipid peroxidation. Timepoint: one time and 1 month after ocp taking. Method of measurement: photometery.
Secondary Outcome Measures
NameTimeMethod
Antioxidant enzymes. Timepoint: one time 1 month after ocp taking. Method of measurement: photometery.
© Copyright 2025. All Rights Reserved by MedPath